CTT PHARMACEUTICAL HOLDINGS, INC.

CTTH
About the company

CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company's technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion.

Country: United StatesPrice: $0.06Market Cap: $3.3M

Investment snapshot

6%positive consensus
Scored 1d ago

Positive

1

BUY / PASS

Neutral / negative

3 / 12

NEUTRAL / FAIL

Median fair value

$0.39

+597.7% vs price

Models with upside

2 / 17

Positive margin of safety

Strongest signal

CTTH undervalued: all 2 models price fair value above $0.06 (median $0.39)

Key risk

No clean pass — all 8 investors flag at least one growth criterion

Framework analysis

VerdictMeaning
BUYPositive purchase signal: the framework's buy requirements are met.
PASSThe company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRALNeither a positive nor negative conclusion. It does not mean to hold an existing position.
FAILThe company does not clear the framework's requirements.
RankedRanked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

MetricGraham

Defensive Value

Buffett

Quality Compounder

Lynch

GARP

Greenblatt

Magic Formula

Piotroski

F-Score

Dreman

Contrarian Value

Munger

Quality Focus

Pabrai

Dhandho Framework

Akre

Three-Legged Stool

Marks

Risk-Aware Value

Ackman

Activist Value

Templeton

Global Bargain Hunter

Sleep

Scale Economies Shared

Asness

Systematic Factors

Neff

Low-P/E Total Return

Schloss

Asset-Value Discipline

O'Shaughnessy

Systematic Factor Composite

VerdictFAILFAILFAILNot rankedFAILFAILPASSNEUTRALFAILFAILFAILFAILFAILNEUTRALFAILFAILNEUTRAL
Score
AnalysisChecking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…
Intrinsic Value (annual)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Margin of SafetyN/AN/AN/AN/AN/AN/AN/AN/AN/A+85.7%N/A+85.7%N/AN/AN/AN/AN/A
Financial Basis

Annual history · FY 2014

Latest source filing: 2015-04-14

Score computed: 2026-11-14

Annual history · FY 2014

Latest source filing: 2015-04-14

Score computed: 2026-11-14

Annual history · FY 2014

Latest source filing: 2015-04-14

Score computed: 2026-11-14

Annual history · FY 2014

Latest source filing: 2015-04-14

Score computed: 2026-11-14

Annual history · FY 2014

Latest source filing: 2015-04-14

Score computed: 2026-11-14

Annual history · FY 2014 · Market data at 2026-11-01

Latest source filing: 2015-04-14

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2014

Latest source filing: 2015-04-14

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2014

Latest source filing: 2015-04-14

Score computed: 2026-11-14

Annual history · FY 2014 · Qualitative assessment

Latest source filing: 2015-04-14

Score computed: 2026-11-14

Annual history · FY 2014 · Qualitative assessment

Latest source filing: 2015-04-14

Score computed: 2026-11-14

Annual history · FY 2014 · Market data at 2026-11-01

Latest source filing: 2015-04-14

Score computed: 2026-11-14

Annual history · FY 2014 · Price history 2025-01-01–2026-11-01

Latest source filing: 2015-04-14

Score computed: 2026-11-14

Annual history · FY 2014 · Qualitative assessment

Latest source filing: 2015-04-14

Score computed: 2026-11-14

Annual history · FY 2014 · Price history 2025-01-01–2026-11-01

Latest source filing: 2015-04-14

Score computed: 2026-11-14

Annual history · FY 2014

Latest source filing: 2015-04-14

Score computed: 2026-11-14

Annual history · FY 2014

Latest source filing: 2015-04-14

Score computed: 2026-11-14

Annual history · FY 2014 · Price history 2025-01-01–2026-11-01

Latest source filing: 2015-04-14

Score computed: 2026-11-14

Where It Passes

  • Valuation models100% pass✓ 2▾

    CTTH undervalued: all 2 models price fair value above $0.06 (median $0.39)

    Marks fair value$0.39
    ✓Marks+85.7% margin vs $0.06
    Templeton fair value$0.39
    ✓Templeton+85.7% margin vs $0.06

Where It Falls Short

  • Growth0% pass✓ 2✗ 11▾

    No clean pass — all 8 investors flag at least one growth criterion

    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
    Basic earnings-growth PEG (dividends excluded)P/E 5.6x (growth N/A)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR-70.8%
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    Inventory Growth vs Revenue GrowthN/A (no inventory)
    ✓LynchInventory growth < Revenue growth
    EPS Growth Direction$-0.13 (2010) -> $0.01 (2014)
    ✓DremanPositive over recent years
    EPS CAGR-70.8% CAGR over 3 years
    ✗Dreman> 5% annualized
    Positive Net Income Frequency1/5 years positive
    ✗MarksPositive net income in >= 7 of last 10 years
    3yr Median Revenue Growth
    ✗Ackman>= 5%
    Positive EPS Growth Frequency2/4 years with positive EPS growth
    ✗AckmanPositive EPS growth in >= 3 of last 5 years
    5-Year EPS CAGR-70.8% CAGR over 3 years
    ✗Templeton> 0% (5-year EPS CAGR)
    Revenue growth vs. gross and operating margin trend
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    5-year Revenue CAGR
    ✗SleepCAGR > 7%
    3-5 Year Diluted EPS CAGR-70.8% over 3 years
    ✗Neff7%-20% annualized
  • Efficiency0% pass✗ 11▾

    All 8 investors flag CTTH's efficiency

    Current Ratio
    ✗Graham>= 2.0
    ROIC (3-5 yr avg)-1555.2%
    ✗Buffett> 10%
    ROIC - WACC-1565.2%
    ✗BuffettPositive (WACC = 10%)
    EBIT / (NWC + Net Fixed Assets)
    ✗Greenblatt> 25%
    Current Ratio Change YoY
    ✗PiotroskiIncreased YoY
    Revenue / Total Assets Change YoY
    ✗PiotroskiImproved YoY
    Current Assets / Current Liabilities
    ✗Dreman> 1.5
    Return on Invested Capital
    ✗Munger> 15%
    ROIC (high and growing)FY2012: ROIC=unavailable; FY2013: ROIC=unavailable; FY2014: ROIC=unavailable
    ✗AkreLatest 3 consecutive FYs: ROIC > 15% in each
    Reinvestment Rate x ROIC
    ✗AkreReinvestment Rate * ROIC > 10%
    ROIC (5-year)0/2 years above 12% (latest -131.2%)
    ✗SleepROIC > 12% in a majority of years
  • Profitability6% pass✓ 3✗ 32▾

    15 of 16 flag CTTH's profitability — Graham, Buffett, Lynch +12 more

    Positive EPS (10 years)3/17 years positive
    ✗GrahamPositive EPS every year for 10 years
    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
    Net Income Positive (10+ years)1/17 years positive
    ✗BuffettPositive every year for 10+ years
    ROE (up to 5-year arithmetic mean)-26926.7%
    ✗Buffett> 15% arithmetic mean (app rule)
    Operating Margin (10-yr trend)
    ✗BuffettStable or rising over 10 years
    Free Cash Flow Proxy
    ✗BuffettPositive and growing
    Earnings Variance (10-yr CoV)5.31
    ✗BuffettCoV < 0.3
    Retained Earnings Effectiveness
    ✗Buffett$1 retained -> > $1 market value created
    Basic earnings-growth PEG (dividends excluded)P/E 5.6x (growth N/A)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR-70.8%
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    ROE-45.0%
    ✗Lynch> 15%
    EBIT / Enterprise Value-21.0%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=-21.0%, ROC=None
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Net Income / Total Assets-40.43%
    ✗PiotroskiROA > 0
    ROA Change YoY-302.48% -> -40.43% (delta: +262.05%)
    ✓PiotroskiCurrent ROA > Prior ROA
    (CFO / Total Assets) vs ROACFO/Assets=-4.35%, ROA=-40.43%
    ✓PiotroskiCFO/Assets > ROA
    Gross Margin Change YoY
    ✗PiotroskiImproved YoY
    Pre-Tax Income / Revenue
    ✗Dreman>= 8%
    Net Income / Shareholders' Equity-45.0%
    ✗Dreman> 12%
    Margin of SafetyP/E=5.6x
    ✓PabraiP/B < 1.5 or P/E < 15
    Return on Equity-26926.7% (3-yr avg)
    ✗AkreROE > 20% (3-year avg)
    Discount to Intrinsic ValueN/A (negative normalized EPS)
    ✗Marks>= 20% below intrinsic value
    Positive Net Income Frequency1/5 years positive
    ✗MarksPositive net income in >= 7 of last 10 years
    Operating Income / Revenue
    ✗Ackman>= 15%
    Net Income / Shareholders Equity-45.0%
    ✗Ackman>= 15%
    5-Year EPS CAGR-70.8% CAGR over 3 years
    ✗Templeton> 0% (5-year EPS CAGR)
    Operating Margin Trend
    ✗TempletonNon-negative operating-margin trend over 3 years
    Revenue growth vs. gross and operating margin trend
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    Net income / market capitalization-20.50%; #4576/6340 (top 72.2%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Gross profit / total assets
    ✗AsnessTop 30% of eligible cross-section
    Net income / positive book equity-45.02%; #4148/5226 (top 79.4%)
    ✗AsnessTop 30% of eligible cross-section
    Negative 5-year standard deviation of ROA-2.0661; #5465/5884 (top 92.9%)
    ✗AsnessTop 30% of eligible cross-section
    3-5 Year Diluted EPS CAGR-70.8% over 3 years
    ✗Neff7%-20% annualized
    Positive Diluted-EPS Years3/5 years positive
    ✗Schloss>= 70% positive over 5-10 observed years (app rule)
  • Debt & Leverage8% pass✓ 1✗ 14▾

    11 of 12 flag CTTH's debt & leverage — Graham, Buffett, Lynch +8 more

    LT Debt vs Net Current Assets
    ✗GrahamLT Debt <= Net Current Assets
    Debt/Equity & Interest Coverage
    ✗BuffettD/E < 0.5 AND Interest Coverage > 5x
    Total Debt / Equity
    ✗Lynch< 0.33
    Cash - Long-term Debt
    ✗LynchPositive preferred
    LT Debt / Total Assets Change0.00% -> 0.00%
    ✓PiotroskiDecreased YoY
    Current Assets / Current Liabilities
    ✗Dreman> 1.5✗SchlossCurrent ratio >= 1.50x (app cutoff)
    Total Debt / Shareholders' Equity
    ✗Dreman< 0.8✗Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✗SchlossD/E < 1.00x
    Debt Levels
    ✗MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3
    Interest Coverage & Debt/EBITDA
    ✗MarksInterest Coverage > 3x; Debt/EBITDA < 4x
    Total Debt / Shareholders Equity
    ✗Ackman<= 1.0
    Negative debt-to-equity (higher means less debt)
    ✗AsnessTop 30% of eligible cross-section
  • Verdicts8% pass✓ 1✗ 12▾

    Split decision: 12 FAIL · 3 NEUTRAL · 1 PASS

    Overall verdict
    ✗GrahamFAIL (0/9)✗BuffettFAIL (0/9)✗LynchFAIL (1/7)•GreenblattNot ranked✗PiotroskiFAIL (F-Score 3)✗DremanFAIL (2/11)✓MungerPASS (2/4)•PabraiNEUTRAL (2/3)✗AkreFAIL (0/6)✗MarksFAIL (1/5)✗AckmanFAIL (0/9)✗TempletonFAIL (2/8)✗SleepFAIL (0/6)•AsnessNEUTRAL (Not ranked)✗NeffFAIL (1/6)✗SchlossFAIL (0/7)•OshaughnessyNEUTRAL (Not ranked)
  • Cash Flow10% pass✓ 2✗ 10▾

    9 of 10 flag CTTH's cash flow — Buffett, Lynch, Piotroski +6 more

    Free Cash Flow Proxy
    ✗BuffettPositive and growing
    FCF Positive and Growing
    ✗LynchPositive and growing
    Operating Cash Flow$-0.1M
    ✗PiotroskiCFO > 0
    (CFO / Total Assets) vs ROACFO/Assets=-4.35%, ROA=-40.43%
    ✓PiotroskiCFO/Assets > ROA
    Price / (CFO / Shares)
    ✗Dreman< 8x
    P/E or FCF YieldP/E=5.6x
    ✓PabraiP/E < 15 or FCF Yield > 10%
    FCF Positive
    ✗MarksPositive FCF in majority of recent years
    (OCF - CapEx) / Market Cap
    ✗Ackman>= 4%
    Price / FCF per Share
    ✗Ackman<= 25
    Positive Operating Cash Flow frequency0/5 years positive
    ✗SleepPositive OCF in >= 70% of available years
    Operating Cash Flow - Capital Expenditures
    ✗Neff> $0 (app proxy for a strong fundamental case)
    (Operating cash flow - capex) / market capitalization
    ✗OshaughnessyTop 10% of eligible cross-section
  • Valuation15% pass✓ 6✗ 22▾

    11 of 13 flag CTTH's valuation — Graham, Lynch, Greenblatt +8 more

    Price / 3-yr avg EPS
    ✗Graham<= 15x
    Price-to-Book Ratio
    ✗Graham<= 1.5x
    P/E x P/B
    ✗Graham<= 22.5
    Basic earnings-growth PEG (dividends excluded)P/E 5.6x (growth N/A)
    ✗Lynch< 1.0 (ideally < 0.5)
    EBIT / Enterprise Value-21.0%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=-21.0%, ROC=None
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Price / EPS5.6x
    ✓Dreman< 12x✓Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
    Price / (CFO / Shares)
    ✗Dreman< 8x
    Price / Book Value per Share
    ✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)
    Valuation ReasonablenessP/E=5.6x
    ✓MungerP/E < 25 or Owner Earnings Yield > 5%
    P/E or FCF YieldP/E=5.6x
    ✓PabraiP/E < 15 or FCF Yield > 10%
    P/B or P/E vs. Historical AverageP/E=5.6x
    ✓MarksP/E < 15 or P/B < 2.0
    Discount to Intrinsic ValueN/A (negative normalized EPS)
    ✗Marks>= 20% below intrinsic value
    Price / FCF per Share
    ✗Ackman<= 25
    Price vs. Trailing Low163% of trailing low ($0.03)
    ✗Templeton<= 120% of trailing low (certified split-adjusted live window)
    Net income / market capitalization-20.50%; #4576/6340 (top 72.2%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Positive book equity / market capitalization+0.4553; #3052/6449 (top 47.3%)
    ✗AsnessTop 30% of eligible cross-section
    Price / Diluted EPS5.6x
    ✓NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
    (EPS CAGR % + Dividend Yield %) / P/E
    ✗Neff> 0.7 (Neff's published traditional edge)
    Price / Tangible Book Value per Share
    ✗SchlossP/TBV <= 1.00x (app cutoff)
    Book Value per Share Change-2084.6%
    ✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
    Revenue / market capitalization
    ✗OshaughnessyTop 10% of eligible cross-section
    (Operating cash flow - capex) / market capitalization
    ✗OshaughnessyTop 10% of eligible cross-section
    Trailing six-month price return through the evaluation date-14.00%; #3662/6202 (top 59.0%)
    ✗OshaughnessyTop 10% of eligible cross-section

Business & financials

Financial snapshot: annual FY 2014. Current investor scores may use newer quarterly data.

Company Profile

Industry: Precious Metals
SIC Sector: Metal Mining
Size: Micro Cap($3.3M)
Revenue: N/A
Net Income: $-672162.00-3454.3% YoY

Financial Snapshot

Operating Margin--
Return on Equity-45.0%
Debt / Equity--
Current Ratio--
EPS (Diluted)$0.01

Similar Companies

AEMAGNICO EAGLE MINES LTD
$90.2B
BBARRICK MINING CORP
$61.2B
GFIGOLD FIELDS LTD
$31.6B
KGCKINROSS GOLD CORP
$24.5B

Company Financials

Latest TTM and quarters alongside annual years

TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

MetricFY 2014
Sources
  • 10-K · 2015-04-14
FY 2013
Sources
  • 10-K · 2014-02-10
FY 2012
Sources
  • 10-K · 2013-03-08
FY 2011
Sources
  • 10-K · 2012-03-20
FY 2010
Sources
  • 10-K · 2012-03-20
Market Cap$3.3Mcurrent$465.0Kest.$3.3Mest.$14.1Mest.$83.0Mest.
Revenue----------
Operating Income-$672.2K↓3454%-$18.9K↑98%-$1.2M↓58%-$757.9K↑63%-$2.1M
Net Income-$672.2K↓3454%-$18.9K↑98%-$1.0M↓127%$3.7M↑441%-$1.1M
EPS (Diluted)$0.01$0.01↑109%$-0.11↓127%$0.40↑408%$-0.13
Gross Margin—————
Operating Margin—————
ROE-45.0%↓170%64.5%↓99%5015.9%↑512%819.0%↑101%-81554.2%
Total Debt------$0↓100%$150.0K
Shareholders' Equity$1.5M↑5191%-$29.3K↓47%-$20.0K↓104%$456.4K↑33812%$1.3K
Current Ratio—0.03↓93%0.34↑71%0.20↓63%0.55
Debt / Equity———0.00↓100%111.44
Operating Cash Flow-$72.3K↓34469%-$209↑100%-$1.0M↓225%-$316.1K↑81%-$1.7M
Free Cash Flow----------

Score history

Historical Score Timeline

Industry peers

Industry Peers

Similar companies in Precious Metals

CTTH vs Peers — Financial Grading

RevenueN/A
Net Income$-672162.00Bottom 25%
ROE-45.0%Bottom 25%
D/E—
Op. Margin—
Curr. Ratio—
CompanyMarket CapPriceRevenueNet IncomeROED/EOp. MarginCurr. RatioGrahamBuffettLynchGreenblattPiotroskiDreman
AGNICO EAGLE MINES LTDAEM$90.2B$178.45$11.9B$4.5B18.0%0.01—2.023/95/95/71/3F-Score 95/11
BARRICK MINING CORPB$61.2B$37.59$17.0B$5.0B18.8%0.17—2.923/95/97/73/3F-Score 95/11
GOLD FIELDS LTDGFI$31.6B$35.76$5.2B$1.2B23.9%0.48——2/93/95/70/3F-Score 56/11
KINROSS GOLD CORPKGC$24.5B$20.76$7.1B$2.4B27.9%0.0946.5%2.354/95/97/73/3F-Score 99/11
PAN AMERICAN SILVER CORPPAAS$15.5B$37.50$3.6B$980.0M14.0%0.1034.1%2.693/92/94/70/3F-Score 75/11
Coeur Mining, Inc.CDE$14.3B$13.98$2.1B$585.9M17.7%0.0234.2%2.472/92/92/71/3F-Score 64/11
Equinox Gold Corp.EQX$12.3B$10.31$1.8B$221.5M3.8%0.2723.8%—2/92/93/70/3F-Score 62/11
ALAMOS GOLD INCAGI$12.0B$28.61$1.8B$885.8M19.9%0.0460.7%2.004/92/97/70/3F-Score 87/11